Status:
COMPLETED
Sepraspray™ Laparoscopic Myomectomy Study
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Laparoscopic Myomectomy
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The purpose of this research study is to obtain preliminary data of the safety and effectiveness of Sepraspray in a limited number of patients who are under going a laparoscopic myomectomy. Sepraspray...
Eligibility Criteria
Inclusion
- The patient must be a premenopausal women with myomas associated with clinical symptoms deemed suitable for laparoscopic myomectomy and SLL.
Exclusion
- Pregnant/lactating women.
- The patient has a history of hypersensitivity to exogenous carboxymethylcellulose products and/or hyaluronic acid.
- The patient's procedure resulted in entry of the endometrial cavity, or entry of the bowel including appendectomy.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00624390
Start Date
November 1 2007
End Date
December 1 2008
Last Update
December 14 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Naperville, Illinois, United States
2
Philadelphia, Pennsylvania, United States
3
Austin, Texas, United States